Decalepis arayalpathra
Decalepis arayalpathra · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Decalepis arayalpathra is a significant medicinal plant recognized for its diverse therapeutic potential in traditional medicine. Scientific investigations have highlighted its potent antioxidant properties, which help combat oxidative stress within the body. Furthermore, the plant shows promising efficacy in the treatment and management of peptic ulcers. Recent advancements in biotechnology have led to the development of synthetic seeds to facilitate its controlled propagation. This innovative preparation method offers a sustainable way to preserve and utilize the plant's valuable bioactive compounds.
- Synonyms
- Janakia Arayalpathra
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Decalepis arayalpathra is a botanical species that is often discussed within the context of its taxonomic history. It is important to note that this plant is also recognized by the synonym Janakia arayalpathra. This dual naming convention can sometimes cause confusion for researchers navigating scientific literature. However, understanding these synonymous relationships is essential for accurate identification and classification. Recognizing both names ensures that the plant is correctly documented across various botanical databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Decalepis arayalpathra is a specialized member of the kingdom Plantae. This botanical species belongs to the genus Decalepis, showcasing its unique evolutionary lineage. Within its biological classification, it falls under the order Gentianales and the class Equisetopsida. Furthermore, it is categorized under the family Apocynaceae, which helps researchers understand its specific traits. These diverse taxonomic relationships highlight the intricate place this plant holds within the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Decalepis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Decalepis arayalpathra is a distinctive plant species primarily concentrated within the tropical regions of Asia. Its presence is most notably felt across the vast expanse of the Indian Subcontinent, where it has become well-established. Within this broader range, India serves as a primary habitat for its natural growth and development. Understanding its specific distribution helps researchers map the ecological niche this species occupies. Consequently, its geographical footprint highlights the unique biodiversity found throughout these warm, tropical landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Decalepis arayalpathra serves as a significant biological source for several compounds with notable therapeutic value. Research confirms that the tubers of this plant contain both cinnamic acid and its derivative, 2-Hydroxy-4-methoxybenzaldehyde (HMB). Within the plant's phenylpropylene biosynthesis pathway, cinnamic acid is converted into HMB, marking a critical step in the production of vanillin derivatives. This chemical relationship is essential for understanding the plant's potential in medicinal chemistry. By studying these natural constituents, scientists can better explore new avenues for developing effective anticancer treatments.
Conditions
Decalepis arayalpathra possesses various therapeutic properties attributed to its major phytoconstituent, 2-hydroxy-4-methoxy benzoic acid (HMBA). This medicinal plant provides anti-diabetic, anti-inflammatory, anti-oxidant, and anti-pyretic effects through its chemical compounds. Furthermore, the plant contains precursors like cinnamic acid that can be modified to exhibit significant anticancer potential. Specifically, derivatives found within the plant's biosynthetic pathways demonstrate in-vitro anticancer activity against human lung carcinoma and breast adenocarcinoma cell lines. Together, these biological activities highlight the diverse medicinal value of Decalepis arayalpathra.
Preparations
Decalepis arayalpathra is prepared as a synthetic seed through a novel biotechnological protocol designed for its conservation and propagation. This process involves encapsulating nodal segments within a sodium alginate matrix to create ideal beads for growth. The research identified that a specific mixture of Murashige and Skoog medium optimizes the regrowth frequency and shoot development of these synthetic seeds. Following encapsulation, the microshoots undergo a rooting phase and subsequent acclimatization to ensure successful plant establishment. Ultimately, this synthetic seed technology provides a sustainable method to preserve the genetic stability and medicinal value of the species.